Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists.
Allen, D. R.
Bolt, Amanda H.
Chapman, G. A.
Knight, R. L.
Meissner, J. W. G.
Owen, D. A.
Watson, R. J.
JournalBioorganic & medicinal chemistry letters
RightsArchived with thanks to Bioorganic & medicinal chemistry letters
MetadataShow full item record
The synthesis and biological evaluation of a series of 1-aryl-3-piperidin-4-yl-urea derivatives as small-molecule CXCR3 antagonists is described. SAR studies resulted in significant improvement of potency and physicochemical properties and established the key pharmacophore of the series, and led to the identification of 9t, which exhibits an IC50 of 16 nM in the GTPgammaS35 functional assay.